Institutional Knowledge Map (KMap)
Map
Services
How To Use
About
Toggle theme
Loading...
Menu
Brianna Loughran
Clinical Research Coordinator II
Cancer Center Division
Map Page
Research Area
cancer,
immunotherapy,
clinical trials,
metastasis,
treatment comparison,
cancer treatment,
drug trial,
dose escalation,
solid tumors,
lymphomas
Grants
(3)
A Phase 1 Dose-Escalation Study of FF-10832 for the Treatment of Advanced Solid Tumors and Lymphomas
Active
·
2023
·
$0 / $684.8K
·
External
cancer treatment,
drug trial,
dose escalation,
solid tumors,
lymphomas
A Randomized Open-Label Phase 3 Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer
Active
·
2023
·
$0 / $494.2K
·
External
cancer,
immunotherapy,
clinical trials,
metastasis,
treatment comparison
Actuate 1801. Phase 1/2 Study of 9-ING-41, a Glycogen Synthase Kinase-3 Beta (GSK-3B) Inhibitor, as a Single Agent and Combined with Chemotherapy, in Patients with Refractory Hematologic Malignancies
Active
·
2023
·
$0 / $432.5K
·
External
gsk-3b inhibitor,
hematologic malignancies,
chemotherapy
Collaborations
(8)
Rachna Shroff
Mutual work: 4 Proposals﹒3 Grants
Collaboration Details
Hina Arif Tiwari
Mutual work: 3 Proposals﹒2 Grants
Collaboration Details
Brianna Denton
Mutual work: 2 Grants﹒2 Proposals
Collaboration Details
Diana Dawson
Mutual work: 3 Grants﹒4 Proposals
Collaboration Details
Jaron Solsky
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Page 1 of 2
Previous page
Next page
7+ Collaborators
$0 / $1.6M Funding
